Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSeeing Machines Regulatory News (SEE)

Share Price Information for Seeing Machines (SEE)

Share Price is delayed by 15 minutes
Get Live Data
4.60    -0.05 (-1.08%)
Bid:
4.55
Ask:
4.615
Spread: 0.065 (1.429%)
Market Cap: £220.78m
SEE Live PriceLast checked at - London Stock Exchange

Intraday Seeing Machines Share Chart

AGM Statement

27 Nov 2012 07:01

RNS Number : 0347S
Seeing Machines Limited
27 November 2012
 



 

Seeing Machines Limited

("Seeing Machines" or the "Company")

 

AGM Statement

 

Seeing Machines, the AIM-listed technology company with a focus on vision based human machine interfaces, will tomorrow hold its Annual General Meeting in Canberra, Australia at the Clifton Suites on Northbourne, 100 Northbourne Ave, Canberra ACT 2601, at 5.00pm AEDT.

 

The Chairman, Terry Winters, will provide the following statement at the meeting:

"The Directors believe that the combination of eye and gaze tracking with facial interpretation will be at the core of future waves of technology and applications in computing and entertainment. We believe this will provide significant opportunities, as well as challenges, for Seeing Machines in the future as we increase our R&D effort to achieve a market leading capability.

 

"Seeing Machines also continues to win new business, most significantly within the Driver Safety Solution (DSS) business. This represents a significant vote of confidence in the capabilities of our revamped sales force and refocused products."

 

Commenting on these latest developments, Chief Executive Officer, Ken Kroeger, will make the following remarks:

"DSS has been specifically designed for deployment into fleets and environments where fatigue and operator distraction pose substantial risk to personnel and equipment. We anticipate sales of DSS will grow over the next 18 months as pressure on companies to monitor and manage these risks intensifies.

 

"As well as selling the DSS units, we derive revenue from recurring maintenance, support services and specialist fatigue management consulting, data management, analysis and reporting services. A particular focus for us going forward will be on growing our services income through the DSSi management reporting suite. We see this as a way to enhance our client relationships and improve the quality of earnings, revenue visibility and gross margins."

 

Closing the meeting, Terry Winters will conclude:

"I am pleased to report that in line with the statement made with the preliminary results in September, the first few months of the current financial year commencing 1 July 2012 have shown further strengthening of the Company's sales pipeline. I am therefore very pleased to report the Board is confident in the outlook for the current financial year and beyond."

 

A copy of the slide presentation to made at the Annual General Meeting will be made available on the Company's website: www.seeingmachines.com

 

Enquiries:

 

Seeing Machines Limited

Terry Winters (Chairman)

Ken Kroeger (Managing Director & CEO)

 

+61 (0) 411 411 111

+61 (2) 6103 4700

 

finnCap Ltd

 

Ed Frisby/Ben Thompson (Corporate Finance)

Simon Starr (Corporate Broking)

+44 (0) 20 7220 0500

Walbrook PR Ltd

Helen Westaway (Media Enquiries)Paul Cornelius (Investor Enquiries)

+44 (0) 20 7933 8780

 

 

About Seeing Machines Limited

Seeing Machines is a world leader in the development of premier products and applications that rely on capturing and understanding the behaviour of human faces and eyes. More information is available from our web site: www.seeingmachines.com

About Seeing Machines' Driver Safety Solution (DSS)

The Seeing Machines DSS suite is a rugged, non-invasive platform that uses cutting edge face and eye tracking techniques to deliver information on operator fatigue and distraction. The DSS has been specifically designed for deployment into fleets and environments where fatigue and operator distraction pose substantial risk to personnel and equipment and therefore need to be monitored and managed.

For more information on DSS, go to http://www.seeingmachines.com/product/dss/

About Seeing Machines' Fatigue Management Consulting

Seeing Machines supports its DSS technology with professional and scientific fatigue management consulting and training services designed to build understanding of how businesses can reduce the risk of operator fatigue and support the readiness, implementation and acceptance of its products. Seeing Machines has developed a comprehensive fatigue management framework through combined collaboration with leading fatigue research institutions and hands on experience in the field with organisations who proactively manage fatigue. Seeing Machines also provides detailed fatigue management training for site personnel to better enable them to understand the causes of, and manage their own fatigue. For more information on fatigue management, go to http://www.seeingmachines.com/fatigue-consultancy/

 

About Seeing Machines' faceAPI®

faceAPI® allows users to incorporate Seeing Machines world-class face tracking technology into their own products or applications. faceAPI provides a growing suite of image-processing modules created specifically for tracking and understanding faces and facial features. These powerful tracking modules are combined into a complete API toolkit that delivers a rich stream of information that can be incorporated into our customers' own products or services. Seeing Machines faceAPI® delivers a comprehensive, integrated solution for developing products that leverage real-time face tracking. All image-processing for face tracking is handled internally, removing the need for computer vision experience. For more information on faceAPI®, go to http://www.seeingmachines.com/product/faceapi/

About Seeing Machines' faceLAB®5

Seeing Machines has been creating advanced eye tracking algorithms since the company was founded in 2000. faceLAB®5 is the organisation's eye tracking system that allows researchers to objectively measure human behavior in a wide range of operational conditions and research settings. faceLAB®'s unique eye and facial tracking solution offers users rare flexibility, portability, and accuracy. For more information on faceLAB®, go to http://www.seeingmachines.com/product/facelab/

About Seeing Machines' Truefield® Analyzer (TFA)

Currently going through its final clinical trials, the TFA will make objective visual field testing a clinical reality. It combines objectivity with 'non-contact' ease of use, making it easy for technicians and patients, giving clinicians objectivity when assessing their patients' conditions. Assessing both eyes concurrently, TFA tests are fast and can be run in both full-test and screening modes. The tests' bilateral concurrency allows the consensual light reflex to be exploited to identify bilateral asymmetries improving test accuracy. Most importantly, the TFA makes objective perimetry a clinical reality. For more information on TFA, go to http://www.seeingmachines.com/product/truefield/

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
AGMBKADDABDDBDB
Date   Source Headline
28th Apr 20217:09 amRNSDMS central to improved safety on US roads
26th Apr 20217:00 amRNSDMS award brings OEM customer count to seven
31st Mar 20217:00 amRNSHalf-year results and financial report
22nd Mar 20217:00 amRNSIssue of shares and total voting rights
19th Mar 20217:16 amRNSNotice of Results and Investor Presentation
8th Feb 20217:00 amRNSSEE DMS Available in 2021 Cadillac Escalade
3rd Feb 20217:30 amRNSHolding(s) in Company
1st Feb 20217:00 amRNSHalf year trading update
27th Jan 20217:00 amRNSQualcomm and Seeing Machines collaboration
13th Jan 20214:41 pmRNSSecond Price Monitoring Extn
13th Jan 20214:35 pmRNSPrice Monitoring Extension
13th Jan 20218:48 amRNSHolding(s) in Company
6th Jan 20217:00 amRNSLicense Agreement with OmniVision Technologies
22nd Dec 20207:00 amRNSFleet Update
30th Nov 20209:19 amRNS2020 AGM Results and Board Changes
25th Nov 202011:50 amRNSDirector/PDMR Shareholding
23rd Nov 202010:00 amRNSShare Transfer & Issue of Performance Rights
5th Nov 20208:02 amRNSNotice of AGM
2nd Nov 202011:43 amRNSHolding(s) in Company
2nd Nov 20207:00 amRNSYear End Results
30th Oct 20209:19 amRNSHolding(s) in Company
30th Oct 20207:00 amRNSWebcast Presentation - Year End Results
29th Oct 202011:39 amRNSHolding(s) in Company
29th Oct 20207:00 amRNSHolding(s) in Company
23rd Oct 20207:00 amRNSIssue of Shares & Total Voting Rights
21st Oct 20207:00 amRNSSEE signs MOU with L3Harris Technologies
12th Oct 20207:00 amRNSSEE extends leading DMS to Occupant Monitoring
16th Sep 20207:15 amRNS5 billion kilometres of Guardian driving data
14th Sep 20207:00 amRNSLaunch of DMS Kit on Qualcomm Snapdragon Platform
8th Sep 20209:05 amRNSSecond Price Monitoring Extn
8th Sep 20209:00 amRNSPrice Monitoring Extension
8th Sep 20207:00 amRNSSEE signs MOU with leading Semiconductor Company
2nd Sep 20209:00 amRNSNext Gen Embedded Product Strategy for Auto DMS
14th Aug 202010:55 amRNSShare purchase by PCA of non-executive director
3rd Aug 20207:00 amRNSFY20 Trading Update
7th Jul 20207:00 amRNSUS set to mandate DMS from 2024
19th May 20207:00 amRNSBusiness restructure and Covid measures
14th May 20207:00 amRNSBoard Changes
6th May 202011:05 amRNSSecond Price Monitoring Extn
6th May 202011:00 amRNSPrice Monitoring Extension
5th May 20204:41 pmRNSSecond Price Monitoring Extn
5th May 20204:35 pmRNSPrice Monitoring Extension
14th Apr 20201:53 pmRNSHolding(s) in Company
9th Apr 20207:00 amRNSDirector/PDMR Shareholding
6th Apr 20204:40 pmRNSSecond Price Monitoring Extn
6th Apr 20204:35 pmRNSPrice Monitoring Extension
2nd Apr 20202:06 pmRNSSecond Price Monitoring Extn
2nd Apr 20202:00 pmRNSPrice Monitoring Extension
2nd Apr 202011:00 amRNSPrice Monitoring Extension
1st Apr 20204:40 pmRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.